Tokyo, Japan

Hiroyuki Moritomo

USPTO Granted Patents = 28 

 

 

Average Co-Inventor Count = 8.6

ph-index = 11

Forward Citations = 483(Granted Patents)


Location History:

  • Ibaraki, JP (2004)
  • Tsukuba, JP (2002 - 2011)
  • Chuo-ku, JP (2009 - 2016)
  • Tokyo, JP (2009 - 2020)

Company Filing History:


Years Active: 2002-2020

Loading Chart...
Loading Chart...
Loading Chart...
28 patents (USPTO):Explore Patents

Title: Hiroyuki Moritomo: Innovator in Pharmaceutical Compounds

Introduction

Hiroyuki Moritomo is an accomplished inventor based in Tokyo, Japan, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 28 patents, he has dedicated his career to developing innovative compounds that address critical health issues.

Latest Patents

Among his latest inventions are piperazine derivatives that serve as MCreceptor agonists. These compounds are designed to provide solutions for preventing or treating bladder and urinary tract diseases. The research indicates that these derivatives can be utilized effectively for conditions such as underactive bladder, hypotonic bladder, acontractile bladder, detrusor underactivity, neurogenic bladder, urethral relaxation failure, detrusor-external urethral sphincter dyssynergia, and voiding dysfunctions associated with benign prostatic hyperplasia. The piperazine derivatives created by Moritomo showcase a profound understanding of pharmacological mechanisms, contributing significantly to medical science.

Career Highlights

Hiroyuki Moritomo's career has been marked by his association with prominent organizations, including Astellas Pharma GmbH and the Ludwig Institute for Cancer Research Limited. These experiences have played a pivotal role in shaping his innovative approach to pharmaceutical research and development. His work is characterized by a deep commitment to improving patient outcomes through novel therapeutic options.

Collaborations

Throughout his career, Moritomo has collaborated with notable colleagues, including Masahiko Hayakawa and Minoru Okada. These partnerships have fostered an environment of innovation, allowing Moritomo to leverage diverse expertise and perspectives in his research endeavors.

Conclusion

Hiroyuki Moritomo stands out as a significant figure in the realm of pharmaceutical innovation. His extensive patent portfolio and dedication to developing solutions for complex medical challenges underscore his role as a leading inventor. As he continues to contribute to the field, the impact of his work will undoubtedly be felt in the advancements of healthcare and therapeutic practices.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…